Good morning! We have a section from Mark on Vianet to kick us off today

1.05pm: I've run out of time, have a fantastic weekend everyone. And thanks for all the constructive feedback in the comments in the last few days - plenty to ruminate on!


Companies Reporting

Name (Mkt Cap)RNSSummaryOur view (Author)

Smiths (LON:SMIN) (£6.4bn)

Strategic Update

Focusing on John Crane/Flex-Tek. Other businesses to be divested or demerged. £500m buyback.AMBER/GREEN (Graham)
I like it when companies simplify. Also there is great shareholder orientation on display with the company using its strong balance sheet to enrich shareholders as much as possible.

Tritax Big Box REIT (LON:BBOX) (£3.5bn)

TU

Contracted rent increases by £22.7m. LTV falls to 29%. Enters 2025 with confidence.AMBER/GREEN (Graham)
A pleasant increase in annual contracted rents, coming from both rent reviews and new developments. I don't see anything to dislike and the shares trade at a 20% discount to book value.

James Halstead (LON:JHD) (£736m)

TU

H1 sales are slightly below last year. PBT comparable. Full year PBT expectations are in line.

Avon Technologies (LON:AVON) (£441m)

AGM Statement

In line.AMBER/RED (Graham)
Nothing too objectionable here but shares are already pricing in a good deal of success over the new few years. Has the potential to grow into its market cap.

Alliance Pharma (LON:APH) (£331m)

TU

“The Board continues to anticipate that underlying Group profit in FY 2024 will be in line with FY 2023.”

PINK
(Takeover planned at 62.5p).

Focusrite (LON:TUNE) (£123m)

AGM TU

Content Creation division: channel de-stocking in H1, expected H2 weighting. Audio Reproduction: headwinds in a softening market.AMBER (Graham)
Statement fails to indicate the full-year outlook vs. expectations. Superficially offers value. Profit warning risk.

Tribal (LON:TRB) (£84m)

TU

FY24 revenue ahead, adj. EBITDA substantially ahead of exps. Continued ARR growth for FY25.AMBER/GREEN (Graham)
We've been AMBER/GREEN on this before. Looks interesting on valuation against ARR. Overall growth will be held back in short-term but could improve again from 2026.

Maintel Holdings (LON:MAI) (£40m)

TU

Rev £97.9m (below exp?), EBITDA £10.5m “broadly in line”. Outlook: revenue warning for 2025.

Ground Rents Income Fund (LON:GRIO) (£30m)

Response to possible offer

37.5p “materially undervalues” the company. PUSU deadline is 5th Feb, extension not granted.

Oncimmune Holdings (LON:ONC) (£14m)

TU

Revenue warning for FY August 2025. £4m expected. Seeks finance to extend cash runway.

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here